Deep venous thrombosis of lower extremity
Conditions
Interventions
Sponsors
Affiliated Hospital of Shandong University of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) According to the diagnostic criteria of DVT. (2) Stage belongs to chronic patients. (3) aged from 18 to 70 years old. (4) Smart phone users. (5) Voluntary participation and cooperation with researchers, signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Allergic or other adverse reactions to Sichong tablet or rivaroxaban. (2) Patients with coagulation dysfunction, anemia, and platelet disorders. (3) Patients with hemorrhagic disease in recent 3 months. (4) There are peptic ulcer, malignant tumor, esophageal varices, arteriovenous malformation, hemangioma and other patients with the risk of massive bleeding. (5) Patients with heart, brain and lung diseases and abnormal liver and kidney functions. (6) Thromboangitis, arteritis, Renault syndrome and other inflammatory vascular diseases. (7) Pregnant and lactating women. (8) Previous or existing mental disorders. (9) Poor compliance, difficult to cooperate with the treatment. (10) Incomplete information affects the judge. (11) Chinese and Western drugs or other drug experimenters who are taking part in the treatment of the disease are being used within two weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| platelet;hemoglobin;Venorectomy score;Fibrinogen;Venous recanalization rate;activated partial thromboplastin time;Prothrombin time;aspartate aminotransferase;creatinine;Symptom quantification score;Curative effect of traditional Chinese medical Syndrome;Alanine aminotransferase;Venous insufficiency quality of life scale score; | — |
Countries
China
Contacts
Public ContactWang Yannan
Affiliated Hospital of Shandong University of traditional Chinese Medicine
Outcome results
None listed